Market research
AEMD Aethlon Medical Inc
NASDAQ USD Healthcare
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 8M
- P/E ratio
- Not available
- Analyst target
- 13.25
- Dividend yield
- Not available
- Beta
- 1.21
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- Not available
- Market cap
- 8M
- P/E ratio
- Not available
- Analyst target
- 13.25
- Dividend yield
- Not available
- Beta
- 1.21
About
About Aethlon Medical Inc
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.
Research context
Aethlon Medical Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the AEMD discussion.
5 years, 6 months ago
Aethlon Medical, Inc is currently in a long term uptrend where the price is trading 93.6% above its 200 day moving average.
From a valuation standpoint, the stock is 98.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 26.3.
Aethlon Medical, Inc's total revenue rose by 51.1% to $625K since the same quarter in the previous year.
Its net income has dropped by 198.1% to $-2M since the same quarter in the previous year.
Finally, its free cash flow fell by 73.5% to $-2M since the same quarter in the previous year.
Based on the above factors, Aethlon Medical, Inc gets an overall score of 3/5.